I am an investor who attended the same presentation as you. I'm simply correcting your very misleading and deceptive posts.
As for you dismissing ISN as a comparison, I can't find anything closer actually, apart from the market caps being around $130M apart - everything else is comparable.
Funnily enough, still no sales for ISN or FDA approval ? Just as ISN did, ALT will be a multiple of current levels well before the first PeriCoach is sold.
ALT Price at posting:
2.2¢ Sentiment: Buy Disclosure: Held
